baber/WOPTO huggingface dataset:
Patent JP-3267292-B2 (JP)
IPC: C09K23/28
Filed: 1991-08-08
Granted: 2002-03-18
Abstract: New fluorinated derivatives useful as surfactants or in the transport of drug or markers, or in drug targeting, and preparations containing the derivatives, for medical, cosmetic and veterinary uses, having the formula:  wherein RF is a fluorinated radical, X is a linear or branched alkylene, R1 is H or CH3, R2 is a radical having at least one OH group, R3 is a radical derived from an amino acid or a peptide, 1<=n<=50 and 0<=m<=200 with 0.2<=n/n+m<=1. These derivatives can be used as prodrugs or in formulating pharmaceutical, cosmetic and veterinary preparations, in biology and medicine, notably in compositions acting as carriers of oxygen and other gases, of contrast agents, or as carriers of substances used in therapy, or as carriers of markers.
Patent JP-3618754-B2 (JP)
IPC: A61M1/36
Filed: 1994-11-10
Granted: 2005-02-09
Abstract: The invention provides a system and method for establishing cardiopulmonary bypass and performing an interventional procedure in a patient's heart or great vessel with a minimum of arterial and venous penetrations. In one embodiment, a bypass cannula (180) configured for introduction into a patient's artery includes a blood flow lumen (188) which may be connected to a cardiopulmonary bypass system (92,94,96,100). A catheter shaft (202) is coupled to the bypass cannula, usually within the blood flow lumen, and has a member (216) at its distal end for performing an interventional procedure within the heart or great vessel. In a particular embodiment, the catheter shaft has an expandable member such as an inflatable balloon disposed near its distal for occluding the ascending aorta so as to substantially block all blood flow therethrough for a plurality of cardiac cycles. The catheter shaft has an inner lumen (212) through which cardio-plegic fluid may be delivered upstream of the occluding member to infuse cardio-plegic fluid into the coronary arteries for arresting the heart. The blood flow lumen in the bypass cannula is connected to a cardiopulmonary bypass system, which receives deoxygenated blood from the patient's venous system, oxygenates the blood, and delivers the oxygenated blood to the patient's arterial system through the blood flow lumen. <IMAGE>
Patent JP-2801401-B2 (JP)
IPC: A61P11/08
Filed: 1991-09-25
Granted: 1998-09-21
Abstract: The present invention is directed to a process for preparing formoterol and related compounds and derivatives thereof and their pharmacologically and pharmaceutically acceptable fumarate salts and/or solvates. The present invention is also directed to certain formoterol related compounds per se.
Patent JP-3586282-B2 (JP)
IPC: H04B7/26
Filed: 1996-10-31
Granted: 2004-11-10
Abstract: The invention relates to a data transfer method in a digital cellular radio network, the method comprising channel coding the information to be transferred for transmission. In order to implement a data rate of 14.4 kbit/s in GSM type of cellular radio systems by employing one time slot only for data transmission, the channel coding according to the method of the invention comprises grouping bits to be transmitted in blocks having the minimum size of 288 bits, carrying out convolutional coding for the blocks with a code rate of ½ by using GSM convolutional coding polynomes, and puncturing the bits obtained by deleting bits from each block so that blocks containing no more than 456 bits will be obtained.
Patent JP-3895366-B2 (JP)
IPC: C12N7/01
Filed: 1991-09-23
Granted: 2007-03-22
Abstract: A mutant virus for use as a vaccine, wherein the genome of the virus is defective in respect of a gene essential for the production of infectious virus. In one aspect the mutant virus is capable of protecting a susceptible species immunized therewith against infection by the corresponding wild-type virus. In another aspect, the mutant virus acts as a vector for an immunogenic protein derived from a pathogen and which is encoded by foreign DNA incorporated in the mutant virus. The mutant virus can be produced in a recombinant host cell which expresses a gene complementing the defect. The mutant virus is preferably infectious for the host to be protected, but the defective gene allows expression in the infected host of at least some of the viral genes, which can provoke a cell-mediated immune response.
Patent JP-3593343-B2 (JP)
IPC: C07K16/28
Filed: 1994-02-09
Granted: 2004-11-24
Abstract: A method for the prevention of insulin dependent (type I) diabetes. The method comprises administration of an antibody, polypeptide or other molecule recognizing VLA-4.
Patent JP-3387921-B2 (JP)
IPC: C08F10/00
Filed: 1993-05-10
Granted: 2003-03-17
Abstract: Catalyst systems of the Ziegler-Natta type containing as active components: a) a titanium-containing solid component in the production of which a titanium compound, a compound of magnesium, a halogenating agent and an electron donor component are used, b) an aluminium compound and c) as a further electron donor component, a silicon-organic compound of general formula (I): R?1R?2Si(OR?3)2? in which R?1 is a C1?-C10? alkyl radical or a C3?-C18? cycloalkyl radical, R?2 is a secondary butyl radical and R?3 is a C1?-C8? alkyl radical. The catalyst systems of the invention are particularly suitable for the production of C2?-C10?-alkyl-1-enes.
Patent JP-3493461-B2 (JP)
IPC: C08L53/02
Filed: 1994-03-28
Granted: 2004-02-03
Abstract: A rubber composition suitable as an all-weather tire material having well-balanced wet-skid resistance, low-temperature characteristics and fuel consumption. The composition comprises a random copolymer A with a glass transition temperature of -20  DEG C or above, a random copolymer B with a glass transition temperature of -50  DEG C or below, and a block copolymer C comprising a copolymer A block and a copolymer B block. The copolymers A, B and C are produced by copolymerizing an aromatic vinyl compound with a conjugated diene in the presence of a catalyst based on an alkali metal.
Patent JP-3490446-B2 (JP)
IPC: C11D3/20
Filed: 1994-04-04
Granted: 2004-01-26
Abstract: A cleaning process and water-based cleaning compositions effective for the removal of radionuclides, polychlorinated biphenyls, pesticides, herbicides, and heavy metals from surfaces of all types, more especially porous surfaces, surfaces that contain irregularities and microscopic voids into which contaminants may migrate and lodge thereby creating a substrate below the surface that must also be cleaned, and particulate surfaces. The cleaning blends and processes remove contaminants from porous and irregular surfaces to such a depth below the surface and into the substrate, and to such an extent, that the cleaned surface satisfies current regulations promulgated by the EPA and NRC relating to standards for decontamination. The process also allows sealing of cleaned surfaces, if desired, with an impermeable coating of a synthetic polymeric composition in order to retard subsequent migration of any residual contaminants to the surface.
Patent JP-3398156-B2 (JP)
IPC: H04R29/00
Filed: 1995-05-02
Granted: 2003-04-21
Abstract: PCT No. PCT/EP95/01649 Sec. 371 Date Oct. 29, 1997 Sec. 102(e) Date Oct. 29, 1997 PCT Filed May 2, 1995 PCT Pub. No. WO96/35314 PCT Pub. Date Nov. 7, 1996The process for controlling a programmable or program-controllable hearing aid for in-situ adjustment of said hearing aid to an optimum target gain in one or more frequency bands by establishing the hearing threshold level of the wearer for one or more frequency bands, determining the target input/output response for the detected hearing loss and generating a corresponding parameter set for an ideal input/output response for the detected hearing loss under feedback-free conditions, by setting the control parameter set of a signal processor initially to an input/output response with a gain equal to the maximum target gain, operating the hearing aid in-situ in accordance with said initial input/output response while monitoring said hearing aid for the occurence of any acoustic feedback, and if no noticeable feedback is detected setting said initial parameter set for said input/output response into said hearing aid, and if noticeable acoustic feedback is detected reducing the gain over at least one of said frequency bands while leaving unchanged with respect to said initial parameter set the gain in any other frequency band, to thereby obtain an adjusted input/output response for at least said one frequency band.
Patent JP-2978249-B2 (JP)
IPC: C08L9/06
Filed: 1996-05-06
Granted: 1999-11-15
Abstract: Tire tread compositions comprising a) a first rubber component comprising about 60-90 parts of styrene butadiene rubber (SBR) comprising less than 20 percent by weight of styrene, per hundred parts of rubber (phr); b) a second rubber component comprising about 10-40 phr of nitrile-butadiene rubber (NBR); c) 30-80 phr of carbon black; d) 10-20 phr of silica; e) 1-3 phr of a silane coupling agent; and, optionally, f) a third rubber component comprising about 10-30 phr of a high cis polybutadiene rubber (cis BR). The tire tread compositions provide tires with excellent wet traction and low rolling resistance.
Patent JP-4278178-B2 (JP)
IPC: H04W74/00
Filed: 1997-03-26
Granted: 2009-06-10
Abstract: A method and apparatus for selecting a communication system in accordance with the geographic region in which the subscriber station is located is described. Upon successful acquisition, a system determination processor examines the received system identification information and compares it with system identification information stored in a universal system table to determine the geographical region of the identified communication system. The system determination processor then determines whether the acquired system is the most desirable system for use in the geographical region. If it is the most desirable system for use in the geographical region, the system determination processor selects the acquired system for providing service. If it is not the most desirable system for use in the geographical region, the subscriber station attempts to acquire a more desirable system using information from the universal system table.
Patent JP-3356785-B2 (JP)
IPC: G01N33/53
Filed: 1998-03-13
Granted: 2002-12-16
Abstract: A glycated hemoglobin assay utilizes a simple procedure for the determination of standardized %GHb in whole blood samples correlated to the Diabetes Control and Complications Trial (DCCT). First, a lysed whole blood sample is incubated with a solid phase that is coupled with boronic acid or similar boronate compound through covalent linkage chemistries known in the art. Next, a labeled antibody to human hemoglobin is added and the resulting signal is directly proportional to the %GHb in the sample. The advantages of measuring %GHb using a single determination include high precision and, since the assay is easily automatable, high throughput. With automation, this assay can also be consolidated with other testing on one analyzer. The method according to the various embodiments of the invention thus eliminates the need for two measurements: one for GHb and another for total hemoglobin (THb).
Patent JP-4085341-B2 (JP)
IPC: C08J9/18
Filed: 1998-03-31
Granted: 2008-05-14
Abstract: The invention is directed to a process for preparing porous polymer materials by a combination of gas foaming and particulate leaching steps. The invention is also directed to porous polymer material prepared by the process, particularly having a characteristic interconnected pore structure, and to methods for using such porous polymer material, particularly for tissue engineering.
Patent JP-3264939-B2 (JP)
IPC: A62C35/60
Filed: 1999-04-09
Granted: 2002-03-11
Abstract: The invention provides a wet-type sprinkler system by which the water damage caused when a sprinkler heads function in a wrong way with ensuring a quick extinguishing operation at the time of fire. A suction pipe is provided for the system so as to communicate with a top part of a secondary pipeline 24 of a feed pipe arrangement 20 forming a water supply line from a water supply unit 16 to sprinkler heads 12. Further, a suction unit (an electromagnetic valve 54 and a suction pump 50) for sucking the air in the secondary pipeline section 24 from the top part of the secondary pipeline section 24 is provided onto the suction pipe 52. The suction pipe 52, the suction pump 50 and the electromagnetic valve 54 constitute a negative-pressure-securing section. In the secondary pipeline 24, which is filled with water in a normal condition water is negatively pressurized by the suction operation of the suction unit. The negatively pressurized state of the water is ensured under a normal condition. Thus, water in the secondary pipeline is prevented from unnecessarily being discharged when the sprinkler heads 12 function in a wrong way.  <IMAGE>
Patent MD-1926-B2 (MD)
Title: Process for production of natural dry aromatized wines
Inventor: CIOCLEA TATIANA
IPC: C12G3/06
Filed: 2000-06-19
Abstract: The invention refers to the wine industry and may be used for production of natural dry aromatized wines. Summary of the invention consists in that the vegetable aromatic ingredients are macerated in the subjected to fermentation must, the obtained wine is removed from the yeast, it is clarified, subjected to glueing and filtered, the vegetable aromatic ingredients being preliminarily treated with must, heated up to a temperature of 40_45 degree C within 15_30 min, the duration of maceration constituting 60_90 hours.The result of the invention consists in the preparation of a natural dry aromatized high-grade wine by a simple and inexpensive process.Claims: 1
Patent ES-2379244-B2 (ES)
Title: Hidrogenación selectiva de dienos en la fabricación de mlab.
Inventor: RILEY MARK GARNER
IPC: B01J21/04
Filed: 2010-09-16
Granted: 2012-10-30
Abstract: Se presenta un procedimiento y un catalizador para la hidrogenación selectiva de acetilenos y diolefinas ramificadas para dar olefinas. El procedimiento usa un catalizador que tiene grandes poros, y una cantidad mínima de microporos. El catalizador se diseña para que tenga una mínima resistencia a la difusión a través de grandes poros, y para minimizar la hidrogenación de olefinas para dar parafinas.
Patent ES-2572731-B2 (ES)
Title: Procedimiento de obtención de un artículo termoconformado, perfeccionado
Inventor: MORON RUBIO JOSÉ ANTONIO
IPC: B29C43/52
Filed: 2014-12-01
Granted: 2016-11-16
Abstract: Adición a la patente española P201330736 "Procedimiento de obtención de un artículo termoconformado" está caracterizada porque comprende una primera etapa (1) en donde se dispone un molde con la forma del cuerpo del artículo a conformar donde se bombea poliuretano; una segunda etapa (2), donde se impregna todo el molde de forma homogénea a una temperatura media de 45º; una tercera etapa (3), donde se insertan en el molde la circuitería electrónica, una batería y un módulo calefactor; una cuarta etapa (4), donde se le aplica una presión al molde durante aproximadamente tres minutos, y finalmente, una quinta etapa (5) donde se realiza la apertura del molde y el correspondiente desmoldeado del producto.
Patent AU-2001285906-B2 (AU)
Title: Organophosphorous compositions
Inventor: FLETCHER WILLIAM M
IPC: A01N57/12
Filed: 2001-08-25
Granted: 2006-07-20
Abstract: The efficacy of insecticidal compositions (especially organophosphate insecticides) is enhanced through the blending of the insecticide with fatty acid containing crop oil concentrate.
Patent AU-2002223631-B2 (AU)
Title: Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them
Inventor: HEITSCH HOLGER
IPC: A61P9/04
Filed: 2001-10-20
Granted: 2006-07-06
Abstract: One embodiment of the present invention relates to heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives of the formula (I),in which R(1), R(2), R(3), R(4), Het, X, Y and Z have the meanings indicated in the specification, and to pharmaceutically tolerable salts thereof. The compounds of the invention are valuable pharmaceutically active compounds that have, for example, an at inhibitory action on ATP-sensitive potassium channels in the cardiac muscle and/or in the vagal cardiac nerve and are suitable, for example, for the treatment of disorders of the cardiovascular system such as coronary heart disease, arrhythmias, cardiac insufficiency, cardiomyopathies, decreased contractility of the heart, or vagal dysfunction of the heart, or for the prevention of sudden cardiac death. The invention furthermore relates to processes for the preparation of the compounds of the formula (I) and pharmaceutically tolerable salts thereof, their use, and pharmaceutical preparations comprising them.
Patent AU-2002254896-B2 (AU)
Title: A process for preparing (branched-alkyl) arylsulphonates and a (branched-alkyl) arylsulphonate compositon
Inventor: FENOUIL LAURENT ALAIN
IPC: C07C5/333
Filed: 2002-02-15
Granted: 2007-04-26
Abstract: A process for preparing branched alkyl aromatic hydrocarbons, which process comprises contacting branched olefins with an aromatic hydrocarbon under alkylating conditions, which branched olefins have been obtained by a process which comprises dehydrogenating an isoparaffinic composition over a suitable catalyst which isoparaffinic composition has been obtained by hydrocracking and hydroisomerization of a paraffinic wax and which isoparaffinic composition comprises paraffins having a carbon number in the range of from 7 to 35, of which paraffins at least a portion of the molecules is branched, the average number of branches per paraffin molecule being at least 0.5 and the branching comprising methyl and optionally ethyl branches; a process for preparing (branched-alkyl)arylsulfonates, comprising sulfonating branched alkyl aromatic hydrocarbons which branched alkyl aromatic hydrocarbons have been prepared by the said process for preparing branched alkyl aromatic hydrocarbons; and branched alkyl aromatic hydrocarbon compositions and (branched-alkyl)arylsulfonate compositions which are obtainable by the processes so defined.
Patent AU-2002300272-B2 (AU)
Title: Roadway Delimiting Means
Inventor: SPENGLER BERND E
IPC: E01F9/669
Filed: 2002-07-25
Granted: 2007-05-24
Abstract: The construction consists of concrete elements (1), each with a fence element (2), and connected along their end faces (1.1) by interlocking hook-shaped connection links (3). Located above each connection link is a holder pocket (4), open at the top, for a fence post (5). Each post has a similar hook-shaped connection link (6) directed towards the fence post of the neighboring concrete element. The pocket is formed by a mainly C-shaped metal profile set into the concrete and provided with anchoring reinforcement (8). Each fence element is of round steel bars welded or screwed to the post.
Patent AU-2002318211-B2 (AU)
Title: Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic
Inventor: LEE DAVID
IPC: A61K9/22
Filed: 2002-07-03
Granted: 2007-07-12
Abstract: The invention pertains to a controlled release pharmaceutical tablet containing oxymorphone which produces a mean minimum blood plasma level 12 to 24 hours after dosing for relieving pain.
Patent AU-2002334530-B2 (AU)
Title: Housing arranged in an exhaust gas system for a combustion engine
Inventor: GLAV RAGNAR
IPC: F01N13/02
Filed: 2002-09-11
Granted: 2007-01-25
Abstract: The present invention relates to a converter device intended to be arranged in an exhaust system for a combustion engine. The converter device comprises an outer casing (1), a passage for leading exhaust gases through the converter device, and at least one exhaust cleaning component (7, 10, 25) intended to clean the exhaust gases as they are led through the passage. The design of the convnerter device is such as to allow the fitting of a module (25, 26, 29, 30) which incorporates a component and is made in at least two sizes whereby the different sizes of module (25, 26, 29, 30) exhibit an identical cross-sectional area in a plane (A) but a different extent in a direction perpendicular to said plane (A).
Patent AU-2003290586-B2 (AU)
Title: Allele-specific RNA interference
Inventor: ZAMORE PHILLIP D
IPC: C12N5/02
Filed: 2003-11-04
Granted: 2009-07-02
Abstract: Human diseases caused by dominant, gain-of-function mutations develop in heterozygotes bearing one mutant and one wild-type copy of a gene. Because the wild-type gene often performs important functions, whereas the mutant gene is toxic, any therapeutic strategy must selectively inhibit the mutant while retaining wild-type gene expression. The present invention includes methods of specifically inhibiting the expression of a mutant allele, while preserving the expression of a co-expressed wild-type allele using RNAi, a therapeutic strategy for treating genetic disorders associated with dominant, gain-of-function gene mutations. The invention also includes small interfering RNAs (siRNAs) and small hairpin RNAs (shRNAs) that selectively suppress mutant, but not wild-type, expression of copper zinc superoxide dismutase (SOD1), which causes inherited amyotrophic lateral sclerosis (ALS).
Patent AU-2004239244-B2 (AU)
Title: Clotting factor-Fc chimeric proteins to treat hemophilia
Inventor: PETERS ROBERT T
IPC: C07K16/46
Filed: 2004-05-06
Granted: 2010-01-28
Abstract: A pharmaceutical composition, for treatment of a hemostatic disorder, comprises a chimeric protein and a pharmaceutically acceptable carrier or excipient, wherein said chimeric protein comprises at least a portion of an immunoglobulin constant region which is an FcRn binding partner, a clotting factor selected from Factor VII, a Factor VII analog, Factor VIIa and a Factor VIIa analog, and optionally at least one linker.
Patent AU-2005222573-B2 (AU)
Title: Unit dose delivery system for two-component composition
Inventor: MEYERTHOLEN DARIN J
IPC: A61C5/06
Filed: 2005-03-04
Granted: 2009-10-22
Abstract: The invention includes a delivery system for a composition made of two or more components, the assembly of a container for use in the system, a method for providing a composition, and a delivery system including an applicator and container. In one embodiment, the container includes an outer housing holding a first mass of a first component of the composition, an inner housing holding a second mass of a second component of the composition, and a seal. The first component is a liquid and the mass of the second component conforms to a bottom and side wall of the inner housing. An interference fit exists between the outer housing and the inner housing such that the inner housing seals the first mass within the first chamber. The inner housing has an aperture in a side wall of the second chamber.
Patent AU-2005225038-B2 (AU)
Title: Method for joining rails by friction welding
Inventor: PFEILER JOHANN
IPC: E01B29/44
Filed: 2005-10-18
Granted: 2009-10-29
Abstract: The method involves heating rail ends to a joining temperature by pressing together faces of rails end. The rails are simultaneously moved relative to one another in an oscillating manner with greatest oscillation amplitude. The rail ends are aligned by aligning one of the contours and cross-sections of the rails. The faces are pressed together to join the rails together. The rails have railroad rails or beams.
Patent AU-2005328704-B2 (AU)
Title: Cap attachable, adjustable sunglasses
Inventor: LERNER BRUCE
IPC: A42B1/24
Filed: 2005-07-07
Granted: 2011-02-24
Abstract: Glasses are provided having one temple which is clipped to a cap, preferably to the brim or visor of a cap. The temple is associated with at least one joint which permits the lens portions to be pivoted from a use position before a user's eyes to a storage position along the user's head over one ear.